Cargando…
Development and characterization of gastroretentive sustained-release formulation by combination of swelling and mucoadhesive approach: a mechanistic study
BACKGROUND: Acyclovir has pharmacokinetic limitations, including poor oral bioavailability of 15%–30%, high variability, and short elimination half-life of 2.3 hours. These limitations necessitate frequent administration of acyclovir, up to five times daily, leading to poor patient compliance, which...
Autores principales: | Sankar, R, Jain, Subheet Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3857114/ https://www.ncbi.nlm.nih.gov/pubmed/24348022 http://dx.doi.org/10.2147/DDDT.S52890 |
Ejemplares similares
-
Gastroretentive microballoons of metformin: Formulation development and characterization
por: Yadav, Akash, et al.
Publicado: (2011) -
Mucoadhesive Microparticles for Gastroretentive Delivery: Preparation, Biodistribution and Targeting Evaluation
por: Hou, Jing-Yi, et al.
Publicado: (2014) -
Effect of Different Polymer Concentration on Drug Release Rate and Physicochemical Properties of Mucoadhesive Gastroretentive Tablets
por: Agarwal, Shweta, et al.
Publicado: (2015) -
Formulation and Evaluation of Fixed-Dose Combination of Bilayer Gastroretentive Matrix Tablet Containing Atorvastatin as Fast-Release and Atenolol as Sustained-Release
por: Dey, Sanjay, et al.
Publicado: (2014) -
Formulation and in vitro characterization of cefpodoxime proxetil gastroretentive microballoons
por: Sharma, AK., et al.
Publicado: (2011)